Cellular Dynamics International
Cellular Dynamics is the world's largest producer of fully functional human cells derived from induced pluripotent stem (iPS) cells. In a field only a few decades old, CDI scientists tout 450 years combined of stem cell experience. Building on this expertise, our iCell products provide industrialized quantities of terminally differentiated human cells enabling basic research, efficient drug discovery programs, and reliably predictive toxicity and efficacy screening through in vitro clinical trials.
Reviews
No reviews to display
Latest products
MyCell® Products provide human induced pluripotent stem (iPS) cells and terminally differentiated cells manufactured from your donor samples to mee...
More about the MyCell Products
iCell® Endothelial Cells , interior surface blood vessel cells derived from human induced pluripotent stem (iPS) cells facilitate vascular-targeted...
More about the iCell Endothelial Cells
iCell® Hepatocytes , derived from human induced pluripotent stem (iPS) cells, provide access to commercial quantities of high quality, high purity h...
More about the iCell Hepatocytes
iCell® Neurons , derived from human induced pluripotent stem (iPS) cells, provide a unique in vitro system for preclinical drug discovery, neurotoxi...
More about the iCell Neurons
iCell® Cardiomyocytes , human induced pluripotent stem (iPS) cell-derived cardiomyocytes, aid drug discovery and improve the predictability of drug ...
More about the iCell Cardiomyocytes
Latest news
News
Cellular Dynamics International Opens Facility in California, Leasing Space from the Buck Institute to Derive and Bank Human Induced Pluripotent Stem Cells
01 Apr 2013
-
Cellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines
21 Mar 2013
-
Cellular Dynamics Announces Presentations at the Society of Toxicology’s 52nd Annual Meeting Demonstrating the Expanding Utility of iCell® Products on Toxicology Assay Development
11 Mar 2013
-
Cellular Dynamics to Produce Human iPSC Lines Under cGMP Conditions
17 Jan 2013
-
Cellular Dynamics Announces Agreement with AstraZeneca on Use of iPSC-derived Human Cells in Drug Discovery Research
03 Jan 2013
Application articles
-
Applying Transfection Technologies to Create Novel Screening Models
Cellular Dynamics International30 Apr 2013
-
iCell Neurons - Assessing Neurite Outgrowth Using High Content Screening
Cellular Dynamics International15 Mar 2013
-
High Throughput In Vitro Assessment of Cardiomyocyte Physiology Using iPSC Cells
Cellular Dynamics International12 Nov 2012
-
iCell Endothelial Cells: Assaying Cell Proliferation
Cellular Dynamics International24 Sep 2012
-
iCell Cardiomyocytes: Assaying Cell Viability
Cellular Dynamics International24 Sep 2012
